Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Pharmacol Biochem Behav. 2012 May 12;102(2):294–301. doi: 10.1016/j.pbb.2012.05.003

Fig. 5.

Fig. 5

Pre-treatment of rats with the 5HT1A receptor antagonist WAY100,635 did not increase catalepsy when compared to saline pre-treatment. No significant effects of treatment, pretreatment, or interaction were found (two-way ANOVA). n=5 rats per group.